The effect on intestinal calcium absorption of somatostatin in man. 1978

D Evensen, and K F Hanssen, and A Berstad

Somatostatin has been detected in the gastrointestinal tract and has been shown to have wide actions on gastrointestinal function. Using an isotope method with 51Cr as a stool marker, we have examined the absorption of 47Ca in 9 healthy volunteers with and without infusion of cyclic somatostatin (250 microgram/h for 2 hours). Both serum and faecal measurements show reduced 47Ca-absorption during somatostatin infusion, net absorption falling from 53.0 +/- 14% without to 40.4 +/- 13% with somatostatin. Possible explanations are discussed with special emphasis on the possibility of an inhibition of active calcium transport, which may be a more general mode of somatostatin action.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

D Evensen, and K F Hanssen, and A Berstad
September 1978, Metabolism: clinical and experimental,
D Evensen, and K F Hanssen, and A Berstad
January 1980, Reproduction, nutrition, developpement,
D Evensen, and K F Hanssen, and A Berstad
January 1977, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
D Evensen, and K F Hanssen, and A Berstad
October 1994, Journal of the American College of Nutrition,
D Evensen, and K F Hanssen, and A Berstad
July 2005, The Journal of clinical endocrinology and metabolism,
D Evensen, and K F Hanssen, and A Berstad
October 1992, Journal of the American College of Nutrition,
D Evensen, and K F Hanssen, and A Berstad
August 1986, Experimental and clinical endocrinology,
D Evensen, and K F Hanssen, and A Berstad
November 1981, Regulatory peptides,
D Evensen, and K F Hanssen, and A Berstad
May 1988, European journal of clinical nutrition,
D Evensen, and K F Hanssen, and A Berstad
September 1977, Journal of the Oslo city hospitals,
Copied contents to your clipboard!